Rigel Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Rok finansowy 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 13 15 16 11 5 17 33 13 0 1 125 5 2 7 8 29 20 4 45 59 109 149 120 117 179
Przychód Δ r/r 0.0% 15.8% 3.2% -30.0% -57.2% 249.2% 102.5% -62.4% -100.0% inf% 16566.7% -96.2% -52.6% 217.8% 15.4% 250.2% -29.5% -78.0% 892.6% 33.2% 83.2% 37.4% -19.4% -2.8% 53.4%
Marża brutto 157.2% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 99.4% 98.5% 99.2% 99.3% 98.5% 93.9% 89.6%
EBIT (mln) -26 -25 -37 -41 -57 -48 -43 -80 -137 -112 35 -86 -99 -89 -91 -52 -70 -80 -73 -69 -29 -9 -54 -20 24
EBIT Δ r/r 0.0% -2.1% 48.3% 10.3% 39.3% -15.7% -10.2% 84.7% 71.9% -18.1% -131.5% -344.6% 15.1% -10.0% 2.0% -43.3% 34.8% 14.2% -8.7% -4.9% -58.1% -69.0% 504.2% -62.2% -218.1%
EBIT (%) -193.0% -163.1% -234.5% -369.3% -1201.5% -290.0% -128.6% -631.2% 0.0% -14938.3% 28.3% -1818.3% -4416.8% -1251.3% -1106.0% -179.1% -342.2% -1775.6% -163.3% -116.5% -26.7% -6.0% -45.1% -17.5% 13.5%
Koszty finansowe (mln) 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 5 4 7 8
EBITDA (mln) -18 -18 -31 -38 -54 -48 -43 -78 -135 -109 37 -84 -99 -85 -91 -52 -58 -80 -73 -67 -28 -9 -54 -17 29
EBITDA(%) -135.8% -118.9% -197.6% -339.0% -1150.7% -282.8% -124.4% -620.5% 0.0% -14519.1% 29.5% -1768.3% -4416.8% -1185.4% -1107.2% -179.3% -286.0% -1791.9% -163.3% -112.3% -26.1% -6.0% -44.5% -14.5% 15.9%
Podatek (mln) 0 0 0 0 -1 0 0 0 -0 -0 0 0 -2 0 -3 -2 4 -2 2 -0 1 1 3 2 1
Zysk Netto (mln) -25 -24 -37 -41 -56 -45 -38 -74 -132 -112 38 -86 -99 -89 -91 -51 -69 -78 -70 -67 -30 -18 -62 -25 17
Zysk netto Δ r/r 0.0% -6.1% 55.6% 11.3% 36.6% -19.6% -16.8% 97.3% 78.2% -15.7% -134.0% -326.9% 15.0% -9.9% 2.1% -43.4% 34.5% 12.7% -9.6% -5.6% -54.3% -41.1% 243.8% -59.3% -169.7%
Zysk netto (%) -191.9% -155.6% -234.5% -372.7% -1188.6% -273.8% -112.4% -589.5% 0.0% -14872.9% 30.3% -1810.0% -4392.9% -1245.1% -1101.9% -178.1% -339.6% -1739.3% -158.3% -112.2% -28.0% -12.0% -51.2% -21.5% 9.8%
EPS -31.43 -5.75 -66.73 -3.62 -3.12 -2.07 -1.51 -2.57 -3.67 -2.73 0.73 -1.36 -1.32 -1.02 -1.04 -0.58 -0.73 -0.62 -0.44 -0.4 -0.18 -0.11 -0.36 -0.14 0.99
EPS (rozwodnione) -31.43 -5.75 -66.73 -3.62 -3.12 -2.07 -1.51 -2.57 -3.67 -2.73 0.72 -1.36 -1.32 -1.02 -1.04 -0.58 -0.73 -0.62 -0.44 -0.4 -0.18 -0.11 -0.36 -0.14 0.99
Ilośc akcji (mln) 1 4 1 11 18 22 25 29 36 41 52 63 75 87 88 88 94 126 161 167 169 170 172 174 18
Ważona ilośc akcji (mln) 1 4 1 11 18 22 25 29 36 41 53 63 75 87 88 88 94 126 161 167 169 170 172 174 18
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD